Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Journal of Health Economics
|
May 4, 2004
On estimators of medical costs with censored data
Anthony O'Hagan, John W Stevens
International Journal of Technology Assessment in Health Care
|
February 27, 2003
Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
John W Stevens, Anthony O'Hagan
BMC Medical Research Methodology
|
March 27, 2002
The probability of cost-effectiveness
Anthony O'Hagan, John W Stevens
Health Economics
|
December 17, 2002
Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
Anthony O'Hagan, John W Stevens
Psychometrika
|
March 28, 2015
Advances in Modeling Model Discrepancy: Comment on Wu and Browne (2015)
Robert C MacCallum, Anthony O'Hagan
International Journal of Technology Assessment in Health Care
|
April 11, 2008
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: addressing the tension between licensing and reimbursement
Christopher McCabe, Karl Claxton, Anthony O'Hagan
Health Economics
|
December 19, 2006
Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
Anthony O'Hagan, Matt Stevenson, Jason Madan
Social Science & Medicine (1982)
|
December 13, 2006
Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method
Samer Kharroubi, John E Brazier, Anthony O'Hagan
Biometrics
|
April 7, 2020
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Biometrics
|
March 7, 2020
Predictively consistent prior effective sample sizes
Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Journal of Health Economics
|
May 4, 2004
On estimators of medical costs with censored data
Anthony O'Hagan, John W Stevens
International Journal of Technology Assessment in Health Care
|
February 27, 2003
Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
John W Stevens, Anthony O'Hagan
BMC Medical Research Methodology
|
March 27, 2002
The probability of cost-effectiveness
Anthony O'Hagan, John W Stevens
Health Economics
|
December 17, 2002
Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
Anthony O'Hagan, John W Stevens
Psychometrika
|
March 28, 2015
Advances in Modeling Model Discrepancy: Comment on Wu and Browne (2015)
Robert C MacCallum, Anthony O'Hagan
International Journal of Technology Assessment in Health Care
|
April 11, 2008
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: addressing the tension between licensing and reimbursement
Christopher McCabe, Karl Claxton, Anthony O'Hagan
Health Economics
|
December 19, 2006
Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
Anthony O'Hagan, Matt Stevenson, Jason Madan
Social Science & Medicine (1982)
|
December 13, 2006
Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method
Samer Kharroubi, John E Brazier, Anthony O'Hagan
Biometrics
|
April 7, 2020
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Biometrics
|
March 7, 2020
Predictively consistent prior effective sample sizes
Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Page
of 3